Bank of America
IBO

Bank of America’s Impact BioMedical IBO Stock Holding History

Bank of America’s Portfolio IBO Stock Details IBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-924
Closed -$467 – 7076
2025
Q4 		$467 Buy
924
+756
+450% +$400 ﹤0.01% 6570
2025
Q3 		$111 Buy
168
+88
+110% +$56 ﹤0.01% 7837
2025
Q2 		$52 Buy
80
+63
+371% +$35 ﹤0.01% 8095
2025
Q1 		$14 Hold
17
– – ﹤0.01% 8186
2024
Q4 		$24 Sell
17
-2,579
-99% -$5.35K ﹤0.01% 8002
2024
Q3 		$5.19K Buy
+2,596
New +$6.14K ﹤0.01% 7003

Other funds holding IBO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return

Bank of America's IBO Position: Q1 2026 in Review

Bank of America sold out of Impact BioMedical (IBO) in Q1 2026, closing a stake of 924 shares — an estimated $467 sold.

Bank of America first reported a position in IBO in Q3 2024 and held it in 6 quarters. The position peaked at $5.19K in Q3 2024. 20 funds tracked by Wall St. Rank hold IBO as of Q1 2026.

  • Bank of America reported no remaining Impact BioMedical position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 924 Impact BioMedical shares in Q1 2026, an estimated $467.
  • Bank of America first reported a position in Impact BioMedical in Q3 2024 and held it in 6 quarters.
  • Bank of America's Impact BioMedical position peaked at $5.19K in Q3 2024.
  • 20 funds tracked by Wall St. Rank held Impact BioMedical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.